Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?

Lemoli, Roberto M; D'Addio, Alessandra

Lemoli, Roberto M; D'Addio, Alessandra.

Lemoli, Roberto M; University of Bologna. Institute of Hematology. Department of Hematology and Oncological Sciences L. & A. Seràgnoli. IT
D'Addio, Alessandra; Azienda Istituti Ospitalieri. Hematology Unit. IT

Rev. bras. hematol. hemoter ; 33(3): 172-173, June 2011.

Article in English | LILACS | ID: lil-596312

Subject(s)

Busulfan/administration & dosage; Leukemia, Myeloid, Acute/drug therapy; Melphalan/administration & dosage; Remission Induction; Hematopoietic Stem Cell Transplantation/methods

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Remission Induction / Busulfan / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Melphalan Language: English Journal: Rev. bras. hematol. hemoter Journal subject: Hematology Year: 2011 Type: Article Affiliation country: Italy Institution/Affiliation country: Azienda Istituti Ospitalieri/IT / University of Bologna/IT

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google